ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

RBGLY Reckitt Benckiser PLC (PK)

11.60
0.02 (0.17%)
21 May 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Reckitt Benckiser PLC (PK) USOTC:RBGLY OTCMarkets Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.02 0.17% 11.60 11.50 11.67 11.6875 11.57 11.68 295,046 21:00:29

Reckitt Benckiser Swung to 2021 Loss Despite Like-for-Like Revenue Rise -- Update

17/02/2022 8:34am

Dow Jones News


Reckitt Benckiser (PK) (USOTC:RBGLY)
Historical Stock Chart


From May 2021 to May 2024

Click Here for more Reckitt Benckiser (PK) Charts.

By Michael Susin

 

Reckitt Benckiser Group PLC on Thursday reported a swing to pretax loss for 2021 despite revenue on a like-for-like basis beating expectations, driven by hygiene products and a recovery in the health division.

The consumer-goods company--which houses Dettol, Harpic and Durex among its brands--posted a pretax loss of 260 million pounds ($353.2 million) for the year compared with a profit of GBP1.87 billion for 2020.

Adjusted operating profit--one of the company's preferred metrics, which strips out exceptional and other one-off items--fell to GBP2.88 billion from GBP3.30 billion the year earlier.

The company reported an operating loss of GBP804 million compared with a profit of GBP2.1 million the previous year.

Excluding the infant formula and child nutrition business in China--which the company agreed to sell to Primavera Capital in June for $2.2 billion and completed on Sept. 9--adjusted operating profit was GBP2.94 billion, matching a consensus taken from the company's website.

Revenue came in at GBP13.23 billion, down from GBP13.99 billion the prior year. Revenue was driven by strong growth in hygiene and a recovery in health, particularly in North America, as price increases were offset by a return to more normalized promotion levels, it said.

Reckitt Benckiser's health business net revenue was GBP4.65 billion and broadly flat on a like-for-like basis.

A consensus estimate taken from the company's website had forecast Reckitt's revenue at GBP13.18 billion, including IFCN China.

The company's net revenue on a like-for-like basis rose 3.5%, beating its guidance of between 1% and 3%. Excluding IFCN China, revenue was GBP12.85 billion compared with a forecast of GBP12.80 billion.

For the year ahead, the company has targeted like-for-like net revenue growth of between 1% to 4%.

"We are therefore targeting both growth in like-for-like net revenue and an increase in adjusted operating margin in 2022, despite an unprecedented inflationary environment and ongoing uncertainties created by Covid-19", Chief Executive Officer Laxman Narasimhan said.

The board declared an interim dividend of 174.6 pence, flat on the previous year, reflecting the recommendation of a final dividend of 101.6 pence.

 

Write to Michael Susin at michael.susin@wsj.com

 

(END) Dow Jones Newswires

February 17, 2022 03:19 ET (08:19 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

1 Year Reckitt Benckiser (PK) Chart

1 Year Reckitt Benckiser (PK) Chart

1 Month Reckitt Benckiser (PK) Chart

1 Month Reckitt Benckiser (PK) Chart

Your Recent History

Delayed Upgrade Clock